JP2020505352A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020505352A5 JP2020505352A5 JP2019538525A JP2019538525A JP2020505352A5 JP 2020505352 A5 JP2020505352 A5 JP 2020505352A5 JP 2019538525 A JP2019538525 A JP 2019538525A JP 2019538525 A JP2019538525 A JP 2019538525A JP 2020505352 A5 JP2020505352 A5 JP 2020505352A5
- Authority
- JP
- Japan
- Prior art keywords
- alpha
- asn
- phe
- trp
- lys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022193564A JP7819087B2 (ja) | 2017-01-18 | 2022-12-02 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
| JP2025088409A JP2025162551A (ja) | 2017-01-18 | 2025-05-28 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762447778P | 2017-01-18 | 2017-01-18 | |
| US62/447,778 | 2017-01-18 | ||
| PCT/US2018/014257 WO2018136646A1 (en) | 2017-01-18 | 2018-01-18 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022193564A Division JP7819087B2 (ja) | 2017-01-18 | 2022-12-02 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020505352A JP2020505352A (ja) | 2020-02-20 |
| JP2020505352A5 true JP2020505352A5 (https=) | 2021-02-25 |
Family
ID=62908287
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019538525A Withdrawn JP2020505352A (ja) | 2017-01-18 | 2018-01-18 | インターロイキン−２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
| JP2022193564A Active JP7819087B2 (ja) | 2017-01-18 | 2022-12-02 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
| JP2025088409A Pending JP2025162551A (ja) | 2017-01-18 | 2025-05-28 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022193564A Active JP7819087B2 (ja) | 2017-01-18 | 2022-12-02 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
| JP2025088409A Pending JP2025162551A (ja) | 2017-01-18 | 2025-05-28 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20200207822A1 (https=) |
| EP (1) | EP3570864B1 (https=) |
| JP (3) | JP2020505352A (https=) |
| AU (1) | AU2018210174B2 (https=) |
| CA (1) | CA3049889A1 (https=) |
| WO (1) | WO2018136646A1 (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2968443T3 (da) | 2013-03-15 | 2021-12-06 | Protagonist Therapeutics Inc | Hepcidinanaloger og anvendelser deraf |
| PT3143037T (pt) | 2014-05-16 | 2021-09-24 | Protagonist Therapeutics Inc | Antagonistas peptídicos tioéter de integrina alfa4beta7 |
| US9624268B2 (en) | 2014-07-17 | 2017-04-18 | Protagonist Therapeutics, Inc. | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| KR20170108936A (ko) | 2014-10-01 | 2017-09-27 | 프로타고니스트 테라퓨틱스, 인코포레이티드 | 신규한 α4β7 펩타이드 단량체 및 이량체 길항제 |
| EP3201217A4 (en) | 2014-10-01 | 2018-07-18 | Protagonist Therapeutics Inc. | Novel cyclic monomer and dimer peptides having integrin antagonist activity |
| US10787490B2 (en) | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| US20190002503A1 (en) | 2015-12-30 | 2019-01-03 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| EP4067368A1 (en) | 2016-06-01 | 2022-10-05 | Athira Pharma, Inc. | Compounds |
| EP3681900A4 (en) | 2017-09-11 | 2021-09-08 | Protagonist Therapeutics, Inc. | OPIOID AGONIST PEPTIDES AND THEIR USES |
| EP3749345A4 (en) | 2018-02-08 | 2022-04-06 | Protagonist Therapeutics, Inc. | CONJUGATED HEPCIDIN MIMETICS |
| TW202019948A (zh) | 2018-07-12 | 2020-06-01 | 美商領導醫療有限公司 | 介白素-23受體之肽抑制劑及其治療發炎疾病之用途 |
| CN114341161A (zh) * | 2019-07-10 | 2022-04-12 | 领导医疗有限公司 | 白细胞介素-23受体的肽抑制剂及其用于治疗炎症性疾病的用途 |
| TW202116793A (zh) * | 2019-07-10 | 2021-05-01 | 美商領導醫療有限公司 | 介白素-23受體之肽抑制劑及其於治療發炎疾病的用途 |
| HRP20250769T1 (hr) * | 2020-01-15 | 2025-08-29 | Janssen Biotech, Inc. | Peptidni inhibitori receptora za interleukin-23 i njihova uporaba u liječenju upalnih bolesti |
| AU2021209086A1 (en) * | 2020-01-15 | 2022-08-04 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| AU2021383828A1 (en) | 2020-11-20 | 2023-07-06 | Janssen Pharmaceutica Nv | Compositions of peptide inhibitors of interleukin-23 receptor |
| WO2023288019A2 (en) | 2021-07-14 | 2023-01-19 | Janssen Biotech, Inc. | Lipidated peptide inhibitors of interleukin-23 receptor |
| CA3226539A1 (en) * | 2021-07-14 | 2023-01-19 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor |
| CN118354781A (zh) | 2021-12-01 | 2024-07-16 | 西兰制药公司 | 白介素-23受体的肽抑制剂 |
| CA3260606A1 (en) | 2022-06-30 | 2024-01-04 | Sanofi | NEW PEPTIDES FOR USE AS SELECTIVE IL-23 RECEPTOR ANTAGONISTS |
| CN120019064A (zh) * | 2022-07-14 | 2025-05-16 | 詹森药业有限公司 | Il-23的环肽抑制剂 |
| WO2024155552A1 (en) * | 2023-01-16 | 2024-07-25 | Janssen Pharmaceutica Nv | Formulations of lipidated peptide inhibitors of interleukin-23 receptor |
| EP4471048A1 (en) | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| EP4471049A1 (en) | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| CN121909205A (zh) | 2023-09-08 | 2026-04-21 | 赛诺菲 | 作为选择性il-23受体抑制剂的新型肽 |
| WO2025051920A1 (en) | 2023-09-08 | 2025-03-13 | Sanofi | New peptides as selective il-23 receptor inhibitors |
| WO2025170982A2 (en) | 2024-02-06 | 2025-08-14 | Paragon Therapeutics, Inc. | Il-23 antibody compositions and methods of use |
| WO2026013260A1 (en) | 2024-07-12 | 2026-01-15 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| WO2026057052A1 (zh) * | 2024-09-14 | 2026-03-19 | 深圳信立泰药业股份有限公司 | 一种il-23受体抑制剂及其制备方法和用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030166138A1 (en) * | 2002-02-21 | 2003-09-04 | Todd Kinsella | Cyclic peptides and analogs useful to treat allergies |
| AU2008216265B2 (en) | 2007-02-15 | 2014-04-03 | Indiana University Research And Technology Corporation | Glucagon/GLP-1 receptor co-agonists |
| CA2707840A1 (en) | 2007-08-20 | 2009-02-26 | Allozyne, Inc. | Amino acid substituted molecules |
| US8946150B2 (en) | 2011-06-14 | 2015-02-03 | Medical Diagnostic Laboratories, LLC. | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| US9605027B2 (en) * | 2011-06-14 | 2017-03-28 | Medical Diagnostic Laboratories, Llc | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| US9624268B2 (en) * | 2014-07-17 | 2017-04-18 | Protagonist Therapeutics, Inc. | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| HK1257747A1 (zh) | 2015-07-15 | 2019-10-25 | Protagonist Therapeutics Inc. | 白细胞介素-23受体的肽抑制剂以及其治疗炎症性疾病的用途 |
| US20200064357A1 (en) * | 2016-11-09 | 2020-02-27 | Protagonist Therapeutics, Inc. | Methods for determining and monitoring gastrointestinal inflammation |
-
2018
- 2018-01-18 WO PCT/US2018/014257 patent/WO2018136646A1/en not_active Ceased
- 2018-01-18 JP JP2019538525A patent/JP2020505352A/ja not_active Withdrawn
- 2018-01-18 US US16/478,733 patent/US20200207822A1/en not_active Abandoned
- 2018-01-18 EP EP18741939.5A patent/EP3570864B1/en active Active
- 2018-01-18 CA CA3049889A patent/CA3049889A1/en active Pending
- 2018-01-18 AU AU2018210174A patent/AU2018210174B2/en active Active
-
2022
- 2022-12-02 JP JP2022193564A patent/JP7819087B2/ja active Active
-
2023
- 2023-01-13 US US18/097,077 patent/US20240132558A1/en active Pending
-
2025
- 2025-05-28 JP JP2025088409A patent/JP2025162551A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020505352A5 (https=) | ||
| JP7403507B2 (ja) | 薬物としてアマトキシンの誘導体を有する抗体薬物コンジュゲート | |
| JP2015533833A5 (https=) | ||
| US20240173427A1 (en) | Glypican 3 antibodies and conjugates thereof | |
| JP2021530477A5 (https=) | ||
| JP2018522008A5 (https=) | ||
| TWI907646B (zh) | 依喜替康（exatecan）衍生物之用途 | |
| CN106456608B (zh) | 抗her2抗体-美登木素缀合物及其使用方法 | |
| JP2016518351A5 (https=) | ||
| JP2020079237A (ja) | 抗ｈｅｒ２抗体−薬物コンジュゲート | |
| JP2010530849A5 (https=) | ||
| JP2017530090A5 (https=) | ||
| JP7109613B2 (ja) | 抗ｃｄ２２抗体－メイタンシンコンジュゲートおよびその使用方法 | |
| JP2017522362A5 (https=) | ||
| CN114502201A (zh) | 靶向性树枝状体缀合物 | |
| WO2012040259A2 (en) | Modified compstatin with improved stability and binding properties | |
| JPWO2020014646A5 (https=) | ||
| JPS60156700A (ja) | トリペプチド化合物、その製造法および医薬組成物 | |
| JPWO2021146454A5 (https=) | ||
| JP2024012517A5 (https=) | ||
| JPWO2021007433A5 (https=) | ||
| WO2024227437A1 (zh) | 白介素-23受体的肽抑制剂制备及其用途 | |
| JP2025508779A (ja) | 抗体及びその薬物コンジュゲート並びに用途 | |
| JPWO2020037434A5 (https=) | ||
| CN120267848A (zh) | 一种抗体偶联药物及其用途 |